Fecal occult blood testing, a patient-administered test that is much less expensive than a colonoscopy, is a valid option for early detection of colon cancer, according to a report in the Canadian ...

Expensive colonoscopies that cost a patient over $1,000 on average could soon be replaced by simpler and much cheaper tests as non-invasive screening options become more available and more ...

Contextual socio-economic factors, health-care access, and general practitioner (GP) involvement may influence colonoscopy uptake and its timing after positive faecal occult blood testing (FOBT). Our ...

The devastating statistics about deaths from colon cancer have put the spotlight on a dreaded disease, which, today, could be ...

The incremental cost per life-year saved by flexible sigmoidoscopy screening was A$16 801 compared with no screening, which is considered cost-effective in terms of health interventions. A figure of ...

How important is screening for colon cancer? It’s very important, according to a study in the July issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the ...

Physicians should screen for colorectal cancer in asymptomatic, low-risk adults aged 50 to 74 years every two years using fecal occult blood testing (FOBT), or flexible sigmoidoscopy every 10 years, ...

People may be more likely to get colorectal cancer screenings when doctors let them choose what type of test to have, a U.S. study suggests. Researchers focused on two widely used screenings. One, a ...

Overall, 44.4% (55 of 124) of the programs assessed used colonoscopy as the primary screening test; 31.5% (n = 39) used FOBT/FIT, and 24.2% (n = 30) used both tests (Table 1). Of the programs that ...

June 17 -- TUESDAY, June 16 (HealthDay News) - CT colonography, a less invasive option to colonoscopy, is an effective way to detect colon cancer in people who have an elevated risk of the disease ...

Nothing elicits a groan from patients as quickly as discussion of uncomfortable screening procedures. Yet those discussions must take place. Colorectal cancer is the third-most common cancer in the ...